<VariationArchive VariationID="2016199" VariationName="NC_000015.10:g.25375764del" VariationType="Deletion" Accession="VCV002016199" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2075405" VariationID="2016199">
      <GeneList>
        <Gene Symbol="SNHG14" FullName="small nucleolar RNA host gene 14" GeneID="104472715" HGNC_ID="HGNC:37462" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>15q11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="24823608" stop="25419462" display_start="24823608" display_stop="25419462" Strand="+" />
          </Location>
          <OMIM>616259</OMIM>
        </Gene>
        <Gene Symbol="UBE3A" FullName="ubiquitin protein ligase E3A" GeneID="7337" HGNC_ID="HGNC:12496" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>15q11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="25333728" stop="25439056" display_start="25333728" display_stop="25439056" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="25582395" stop="25684174" display_start="25582395" display_stop="25684174" Strand="-" />
          </Location>
          <OMIM>601623</OMIM>
          <Haploinsufficiency last_evaluated="2012-08-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=UBE3A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-08-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=UBE3A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000015.10:g.25375764del</Name>
      <CanonicalSPDI>NC_000015.10:25375762:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="25375763" stop="25375763" display_start="25375763" display_stop="25375763" variantLength="1" positionVCF="25375762" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="25620910" stop="25620910" display_start="25620910" display_stop="25620910" variantLength="1" positionVCF="25620909" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.25375764del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.25375764del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.25620911del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.25620911del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009268.1" sequenceAccession="NG_009268" sequenceVersion="1" change="g.68219del">
            <Expression>NG_009268.1:g.68219del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_15" sequenceAccession="LRG_15">
            <Expression>LRG_15:g.68219del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000015.10:g.25375764del AND Angelman syndrome" Accession="RCV002851452" Version="2">
        <ClassifiedConditionList TraitSetID="2168">
          <ClassifiedCondition DB="MedGen" ID="C0162635">Angelman syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-25" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25212744</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29737008</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-17">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="2168" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="404" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Happy puppet syndrome (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HAPPY PUPPET SYNDROME</ElementValue>
                <XRef Type="MIM" ID="105830" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Angelman syndrome</ElementValue>
                <XRef ID="Angelman+Syndrome/452" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007113" DB="MONDO" />
                <XRef ID="76880004" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AS</ElementValue>
                <XRef Type="MIM" ID="105830" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Angelman syndrome (AS) is characterized by severe developmental delay or intellectual disability, severe speech impairment, gait ataxia and/or tremulousness of the limbs, and unique behavior with an apparent happy demeanor that includes frequent laughing, smiling, and excitability. Microcephaly and seizures are also common. Developmental delays are first noted at around age six months; however, the unique clinical features of AS do not become manifest until after age one year.</Attribute>
                <XRef ID="NBK1144" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5810" />
                <XRef ID="5810" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">imprinting disorder</Attribute>
                <XRef ID="GTR000260593" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000226643" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519582" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000503131" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000260593" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508937" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509438" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522320" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529013" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551668" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558906" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592359" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520996" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521642" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525860" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525867" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530102" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552178" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552326" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556612" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558216" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568371" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000331374" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507771" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508896" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519272" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520979" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520995" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520998" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558805" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527540" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000531722" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552341" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556577" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558215" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568029" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">AS is caused by disruption of maternally imprinted UBE3A located within the 15q11.2-q13 Angelman syndrome/Prader-Willi syndrome (AS/PWS) region.</Attribute>
                <XRef ID="GTR000501320" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301323</ID>
                <ID Source="BookShelf">NBK1144</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2001">
                <ID Source="pmc">3111049</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="Eurogentest, 2008">
                <URL>http://www.eurogentest.org/web/files/public/unit3/ClinicalUtilityGeneCards/Indication%20criteria%20-%20AS.pdf</URL>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23519317</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/ASHG, 2015">
                <ID Source="PubMed">25782669</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27467454</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2020">
                <ID Source="PubMed">32296163</ID>
              </Citation>
              <XRef ID="72" DB="Orphanet" />
              <XRef ID="C0162635" DB="MedGen" />
              <XRef ID="MONDO:0007113" DB="MONDO" />
              <XRef Type="MIM" ID="105830" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5909500" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="17073369|MedGen:C0162635" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003219827" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25212744</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29737008</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 2016199). Disruption of the initiator codon has been observed in individual(s) with Angelman syndrome (PMID: 25212744, 29737008). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change affects the initiator methionine of the UBE3A mRNA. The next in-frame methionine is located at codon 40.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="UBE3A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.25620910del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0162635" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5909500" TraitType="Disease" MappingType="XRef" MappingValue="C0162635" MappingRef="MedGen">
        <MedGen CUI="C0162635" Name="Angelman syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

